The allelic frequency for S and Z mutations in the SERPINA1 gene in NSCLC patients from Poland

M. Komorowski (Warszawa, Poland)

Source: International Congress 2017 – Gene signatures in bronchial diseases
Session: Gene signatures in bronchial diseases
Session type: Poster Discussion
Number: 4953

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Komorowski (Warszawa, Poland). The allelic frequency for S and Z mutations in the SERPINA1 gene in NSCLC patients from Poland. 4953

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Novel genetic variants in alpha-1 antitripsin deficiency cases carrying S alleles and discordant genotype and serum levels
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015

SERPINA1 gene variants in subjects from a general population with reduced alpha1-antitrypsin level
Source: Annual Congress 2008 - COPD
Year: 2008


The influence of the polymorphism at codon 72 of exon 4 of the P53 gene and GSTM1 and GSTT1 null in lung cancer risk in a Brazilian population
Source: Eur Respir J 2006; 28: Suppl. 50, 812s
Year: 2006

M2 allele of alpha1-antitrypsin gene and genetic susceptibility to COPD in Korean men
Source: Eur Respir J 2005; 26: Suppl. 49, 442s
Year: 2005

Arg72Pro P53 gene polymorphism is associated with P53 mutations in non-small cell lung cancer (NSCLC) patients
Source: Eur Respir J 2004; 24: Suppl. 48, 78s
Year: 2004

High frequency of CFTR R75Q variant and mEPHX „slow" allele in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 343s
Year: 2005

Evaluation of EGFR mutations and ERCC2 polymorphisms in treatment of non-small cell lung cancer
Source: Annual Congress 2005 - Chemotherapy and palliative care
Year: 2005


Arg72Pro and GSTM1 gene polymorphisms increase the risk of non small cell lung cancer (NSCLC)
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005

Association of -93G®A polymorphism in the hMLH1 gene with susceptibility to and prognosis of non-small cell lung cancer in Taiwan
Source: Eur Respir J 2006; 28: Suppl. 50, 151s
Year: 2006

The analysis of CHEK2 gene mutation in small cell lung cancer
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021

Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients
Source: Eur Respir Rev 2014; 23: 390-392
Year: 2014


Association of polymorphism of the human nm23-H1 gene (NME1) with susceptibility to and severity of non-small cell lung cancer
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007


Interpopulation differences of allele and genotype frequencies of 12 SNP markers in 8 asthma susceptibility genes in Russians and Buryats
Source: Annual Congress 2010 - Genetics of obstruction
Year: 2010

p53 gene mutations in lung cancer in Korean
Source: Eur Respir J 2005; 26: Suppl. 49, 327s
Year: 2005

Description of new CFTR gene’s mutations in patients of Russia
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020


COPD susceptibility gene on chromosome 4q31 is also associated with lung cancer
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010

NAT2 gene polymorphism in lung cancer: A study from north India
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012


Genotyping single-nucleotide polymorphisms (SNP) in ERCC1, XPD, XRCC1, XRCC3 and MDR-1 and CCND-1 genes for response and toxicity prediction in chemotherapy of non small cell lung cancer (NSCLC)
Source: Annual Congress 2007 - Biology in thoracic oncology
Year: 2007


Evaluation of MRP1-5 gene expression in cystic fibrosis patients homozygous for the ΔF508 mutation
Source: Annual Congress 2003 - Cystic fibrosis: new genes, new controversies
Year: 2003


The correlation between p53 gene mutation and the expression of tumor drug resistance genes in lung cancer and its clinical significance
Source: Annual Congress 2005 - Prognostic factors in lung cancer
Year: 2005